Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

The worst of both worlds-combined deliveries in twin gestations: a subanalysis of the Twin Birth Study, a randomized, controlled, prospective study.

Aviram A, Lipworth H, Asztalos EV, Mei-Dan E, Cao X, Melamed N, Zaltz A, Anastasio HB, Berghella V, Barrett JFR.

Am J Obstet Gynecol. 2019 Oct;221(4):353.e1-353.e7. doi: 10.1016/j.ajog.2019.06.047. Epub 2019 Jun 27.

PMID:
31254526
2.

Response to Comment on Feig et al. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial. Diabetes Care 2018;41:2471-2479.

Feig DS, Corcoy R, Donovan LE, Murphy KE, Barrett JFR, Sanchez JJ, Ruedy K, Kollman C, Tomlinson G, Murphy HR; CONCEPTT Collaborative Group.

Diabetes Care. 2019 Jun;42(6):e98-e99. doi: 10.2337/dci19-0013. No abstract available.

PMID:
31110123
3.

No 369 - Prise en charge de la grossesse aprés une mortinaissance.

Ladhani NNN, Fockler ME, Stephens L, Barrett JFR, Heazell AEP.

J Obstet Gynaecol Can. 2018 Dec;40(12):1684-1700. doi: 10.1016/j.jogc.2018.10.012.

PMID:
30527076
4.

No. 369-Management of Pregnancy Subsequent to Stillbirth.

Ladhani NNN, Fockler ME, Stephens L, Barrett JFR, Heazell AEP.

J Obstet Gynaecol Can. 2018 Dec;40(12):1669-1683. doi: 10.1016/j.jogc.2018.07.002.

PMID:
30527075
5.

Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial.

Feig DS, Corcoy R, Donovan LE, Murphy KE, Barrett JFR, Sanchez JJ, Wysocki T, Ruedy K, Kollman C, Tomlinson G, Murphy HR; CONCEPTT Collaborative Group.

Diabetes Care. 2018 Dec;41(12):2471-2479. doi: 10.2337/dc18-1437. Epub 2018 Oct 16.

PMID:
30327362
6.

Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.

Stockley EL, Ting JY, Kingdom JC, McDonald SD, Barrett JF, Synnes AR, Monterrosa L, Shah PS; Canadian Neonatal Network; Canadian Neonatal Follow-up Network; Canadian Preterm Birth Network Investigators.

Am J Obstet Gynecol. 2018 Dec;219(6):606.e1-606.e8. doi: 10.1016/j.ajog.2018.09.010. Epub 2018 Sep 18.

PMID:
30240651
7.

Planned cesarean or vaginal delivery for women in spontaneous labor with a twin pregnancy: A secondary analysis of the Twin Birth Study.

Mei-Dan E, Dougan C, Melamed N, Asztalos EV, Aviram A, Willan AR, Barrett JFR.

Birth. 2019 Mar;46(1):193-200. doi: 10.1111/birt.12387. Epub 2018 Aug 2.

PMID:
30073688
8.

Comparison of cesarean versus vaginal delivery of extremely preterm gestations in breech presentation: retrospective cohort study.

Niles KM, Barrett JFR, Ladhani NNN.

J Matern Fetal Neonatal Med. 2019 Apr;32(7):1142-1147. doi: 10.1080/14767058.2017.1401997. Epub 2017 Nov 20.

PMID:
29157039
9.

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.

Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, Asztalos E, Barrett JFR, Sanchez JJ, de Leiva A, Hod M, Jovanovic L, Keely E, McManus R, Hutton EK, Meek CL, Stewart ZA, Wysocki T, O'Brien R, Ruedy K, Kollman C, Tomlinson G, Murphy HR; CONCEPTT Collaborative Group.

Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Erratum in: Lancet. 2017 Nov 25;390(10110):2346.

10.

No 347-Prise en charge obstétricale près de la limite de viabilité du fœtus.

Ladhani NNN, Chari RS, Dunn MS, Jones G, Shah P, Barrett JFR.

J Obstet Gynaecol Can. 2017 Sep;39(9):792-804. doi: 10.1016/j.jogc.2017.06.011. French. No abstract available.

PMID:
28859765
11.

No. 347-Obstetric Management at Borderline Viability.

Ladhani NNN, Chari RS, Dunn MS, Jones G, Shah P, Barrett JFR.

J Obstet Gynaecol Can. 2017 Sep;39(9):781-791. doi: 10.1016/j.jogc.2017.03.108.

PMID:
28859764
12.

Beware selection bias.

Barrett JFR, Zaltz A, Geary M, Sermer M, Kingdom J.

CMAJ. 2017 Aug 28;189(34):E1096. doi: 10.1503/cmaj.733261. No abstract available.

13.

Time dependent genetic analysis links field and controlled environment phenotypes in the model C4 grass Setaria.

Feldman MJ, Paul RE, Banan D, Barrett JF, Sebastian J, Yee MC, Jiang H, Lipka AE, Brutnell TP, Dinneny JR, Leakey ADB, Baxter I.

PLoS Genet. 2017 Jun 23;13(6):e1006841. doi: 10.1371/journal.pgen.1006841. eCollection 2017 Jun.

14.

Pregnancy subsequent to stillbirth: Medical and psychosocial aspects of care.

Fockler ME, Ladhani NNN, Watson J, Barrett JFR.

Semin Fetal Neonatal Med. 2017 Jun;22(3):186-192. doi: 10.1016/j.siny.2017.02.004. Epub 2017 Mar 3. Review.

PMID:
28262391
15.

The effect of induction method in twin pregnancies: a secondary analysis for the twin birth study.

Mei-Dan E, Asztalos EV, Willan AR, Barrett JF.

BMC Pregnancy Childbirth. 2017 Jan 6;17(1):9. doi: 10.1186/s12884-016-1201-8.

16.

Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.

Feig DS, Murphy K, Asztalos E, Tomlinson G, Sanchez J, Zinman B, Ohlsson A, Ryan EA, Fantus IG, Armson AB, Lipscombe LL, Barrett JF; MiTy Collaborative Group.

BMC Pregnancy Childbirth. 2016 Jul 19;16(1):173. doi: 10.1186/s12884-016-0954-4.

17.

Exploring Women's Preferences for the Mode of Delivery in Twin Gestations: Results of the Twin Birth Study.

Murray-Davis B, McVittie J, Barrett JF, Hutton EK; Twin Birth Study Collaborative Group.

Birth. 2016 Dec;43(4):285-292. doi: 10.1111/birt.12238. Epub 2016 Jun 20.

PMID:
27321272
18.

Re: Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial: Counselling is difficult when outcomes are associated with mode of delivery and not the plan of mode of delivery.

Hutton EK, Hannah ME, Ross S, Joseph KS, Ohlsson A, Asztalos E, Willan AR, Allen AC, Armson BA, Gafni A, Mangoff K, Sanchez JJ, Barrett JF; Twin Birth Study Collaborative Group.

BJOG. 2016 Mar;123(4):644. doi: 10.1111/1471-0528.13769. No abstract available.

19.

Twin Birth Study: 2-year neurodevelopmental follow-up of the randomized trial of planned cesarean or planned vaginal delivery for twin pregnancy.

Asztalos EV, Hannah ME, Hutton EK, Willan AR, Allen AC, Armson BA, Gafni A, Joseph KS, Ohlsson A, Ross S, Sanchez JJ, Mangoff K, Barrett JF.

Am J Obstet Gynecol. 2016 Mar;214(3):371.e1-371.e19. doi: 10.1016/j.ajog.2015.12.051. Epub 2016 Jan 29.

PMID:
26830380
20.

Planned caesarean section for women with a twin pregnancy.

Hofmeyr GJ, Barrett JF, Crowther CA.

Cochrane Database Syst Rev. 2015 Dec 19;(12):CD006553. doi: 10.1002/14651858.CD006553.pub3. Review.

21.

Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial.

Hutton EK, Hannah ME, Ross S, Joseph KS, Ohlsson A, Asztalos EV, Willan AR, Allen AC, Armson BA, Gafni A, Mangoff K, Sanchez JJ, Barrett JF; Twin Birth Study Collaborative Group.

BJOG. 2015 Nov;122(12):1653-62. doi: 10.1111/1471-0528.13597. Epub 2015 Aug 20.

22.

Pregnancy and risk of a traffic crash.

Redelmeier DA, May SC, Thiruchelvam D, Barrett JF.

CMAJ. 2014 Oct 21;186(15):1169. doi: 10.1503/cmaj.114-0070. No abstract available.

23.

Pregnancy and the risk of a traffic crash.

Redelmeier DA, May SC, Thiruchelvam D, Barrett JF.

CMAJ. 2014 Jul 8;186(10):742-50. doi: 10.1503/cmaj.131650. Epub 2014 May 12.

24.

Twin delivery: method, timing and conduct.

Barrett JF.

Best Pract Res Clin Obstet Gynaecol. 2014 Feb;28(2):327-38. doi: 10.1016/j.bpobgyn.2013.12.008. Epub 2014 Jan 8.

PMID:
24445020
25.

Planned cesarean or vaginal delivery for twin pregnancy.

Barrett JF, Willan AR, Joseph KS.

N Engl J Med. 2014 Jan 16;370(3):280. doi: 10.1056/NEJMc1314560. No abstract available.

PMID:
24428474
26.

A randomized trial of planned cesarean or vaginal delivery for twin pregnancy.

Barrett JF, Hannah ME, Hutton EK, Willan AR, Allen AC, Armson BA, Gafni A, Joseph KS, Mason D, Ohlsson A, Ross S, Sanchez JJ, Asztalos EV; Twin Birth Study Collaborative Group.

N Engl J Med. 2013 Oct 3;369(14):1295-305. doi: 10.1056/NEJMoa1214939. Erratum in: N Engl J Med. 2013 Dec 12;369(24):2364.

27.

Planned caesarean section for women with a twin pregnancy.

Hofmeyr GJ, Barrett JF, Crowther CA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006553. doi: 10.1002/14651858.CD006553.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD006553.

28.

Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa.

Zhang C, Herath K, Jayasuriya H, Ondeyka JG, Zink DL, Occi J, Birdsall G, Venugopal J, Ushio M, Burgess B, Masurekar P, Barrett JF, Singh SB.

J Nat Prod. 2009 May 22;72(5):841-7. doi: 10.1021/np800783b.

PMID:
19334707
29.

Intrahepatic cholestasis of pregnancy in women with a multiple pregnancy: an analysis of risks and pregnancy outcomes.

Lausman AY, Al-Yaseen E, Sam D, Nitsch R, Barrett JFR, Chan WS.

J Obstet Gynaecol Can. 2008 Nov;30(11):1008-1013. doi: 10.1016/S1701-2163(16)32995-4.

PMID:
19126282
30.

Isolation, structure, and antibacterial activity of thiazomycin A, a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa.

Zhang C, Zink DL, Ushio M, Burgess B, Onishi R, Masurekar P, Barrett JF, Singh SB.

Bioorg Med Chem. 2008 Oct 1;16(19):8818-23. doi: 10.1016/j.bmc.2008.08.079. Epub 2008 Sep 6.

PMID:
18804380
31.

Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347.

Zhang C, Occi J, Masurekar P, Barrett JF, Zink DL, Smith S, Onishi R, Ha S, Salazar O, Genilloud O, Basilio A, Vicente F, Gill C, Hickey EJ, Dorso K, Motyl M, Singh SB.

J Am Chem Soc. 2008 Sep 10;130(36):12102-10. doi: 10.1021/ja803183u. Epub 2008 Aug 13.

PMID:
18698773
32.

Control and prevention of MRSA infections.

Wang L, Barrett JF.

Methods Mol Biol. 2007;391:209-25. Review.

PMID:
18025680
33.

Antibacterial evaluations of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa.

Singh SB, Occi J, Jayasuriya H, Herath K, Motyl M, Dorso K, Gill C, Hickey E, Overbye KM, Barrett JF, Masurekar P.

J Antibiot (Tokyo). 2007 Sep;60(9):565-71.

PMID:
17917239
34.

Isolation and structure elucidation of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa.

Jayasuriya H, Herath K, Ondeyka JG, Zhang C, Zink DL, Brower M, Gailliot FP, Greene J, Birdsall G, Venugopal J, Ushio M, Burgess B, Russotti G, Walker A, Hesse M, Seeley A, Junker B, Connors N, Salazar O, Genilloud O, Liu K, Masurekar P, Barrett JF, Singh SB.

J Antibiot (Tokyo). 2007 Sep;60(9):554-64.

PMID:
17917238
35.

Pharmacoeconomics of treatment with the newer anti-Gram-positive agents.

Wang L, Barrett JF.

Expert Opin Pharmacother. 2006 May;7(7):885-97. Review.

PMID:
16634711
36.

Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.

Liu M, Healy MD, Dougherty BA, Esposito KM, Maurice TC, Mazzucco CE, Bruccoleri RE, Davison DB, Frosco M, Barrett JF, Wang YK.

Eukaryot Cell. 2006 Apr;5(4):638-49.

37.

Antibacterial drug discovery--then, now and the genomics future.

Monaghan RL, Barrett JF.

Biochem Pharmacol. 2006 Mar 30;71(7):901-9. Epub 2006 Feb 21. Review.

PMID:
16494849
38.

Discovery of FabH/FabF inhibitors from natural products.

Young K, Jayasuriya H, Ondeyka JG, Herath K, Zhang C, Kodali S, Galgoci A, Painter R, Brown-Driver V, Yamamoto R, Silver LL, Zheng Y, Ventura JI, Sigmund J, Ha S, Basilio A, Vicente F, Tormo JR, Pelaez F, Youngman P, Cully D, Barrett JF, Schmatz D, Singh SB, Wang J.

Antimicrob Agents Chemother. 2006 Feb;50(2):519-26.

39.

What are we looking for in new antibacterials and how do we design it?

Barrett JF, Motyl M.

Expert Opin Investig Drugs. 2006 Feb;15(2):85-8.

PMID:
16433588
40.

Empirical antibacterial drug discovery--foundation in natural products.

Singh SB, Barrett JF.

Biochem Pharmacol. 2006 Mar 30;71(7):1006-15. Epub 2006 Jan 19. Review.

PMID:
16412984
41.

Overview of anti-infective drug development.

Barrett JF.

Curr Protoc Pharmacol. 2006 Jan;Chapter 13:Unit13A.1. doi: 10.1002/0471141755.ph13a01s31. Review. No abstract available.

PMID:
21953396
42.

Potential risk of probiotic usage.

Barrett JF.

Expert Opin Drug Saf. 2006 Jan;5(1):3-4. No abstract available.

PMID:
16370949
43.

Bacterial resistance.

Lawrence LE, Pucci MJ, Discotto L, Barrett JF.

IDrugs. 1998 Dec;1(8):850-9. No abstract available.

PMID:
16196471
44.

Can biotech deliver new antibiotics?

Barrett JF.

Curr Opin Microbiol. 2005 Oct;8(5):498-503. Review.

PMID:
16125445
45.

Recent developments in glycopeptide antibacterials.

Barrett JF.

Curr Opin Investig Drugs. 2005 Aug;6(8):781-90. Review.

PMID:
16121684
46.

Quinolone update.

Barrett JF, Lawrence LE.

IDrugs. 1999 Dec;2(12):1244-7. No abstract available.

PMID:
16113943
47.

Targets, targets everywhere--so where are the new antibacterial drugs?

Pucci MJ, Dougherty TJ, Barrett JF.

IDrugs. 2000 Mar;3(3):249-50. No abstract available.

PMID:
16103924
48.

American Society of Microbiology - 100th General Meeting.

Dougherty TJ, Pucci MJ, Zawadzke L, Barrett JF.

IDrugs. 2000 Aug;3(8):857-60.

PMID:
16059795
49.

Antifungal agents and efflux pump inhibitors.

Arikan S, Barrett JF.

IDrugs. 2000 Dec;3(12):1411-5. No abstract available.

PMID:
16037843
50.

What will genomics bring to the finish line?

Dougherty TJ, Pucci MJ, Davison DB, Barrett JF.

IDrugs. 2001 Apr;4(4):373-4. No abstract available.

PMID:
16015466

Supplemental Content

Loading ...
Support Center